Here are five things to know:
1. Many consolidation activity is due to biotech firms and product lines growing to compensate for older products whose sales are declining.
2. Abbot plans to purchase St. Jude Medical in a $25 billion transaction.
3. Sanofi put forth an offer to acquire Medivation for nearly $9.3 billion, and AbbVie penned a $5.8 billion deal to acquire Stemcentrx.
4. Many healthcare companies are merging in response to new payment methods and new regulation.
5. Some regulations successfully blocked mergers, including the $150 billion Pfizer and Allergan merger, which was essentially banned due to new inversion regulations.
More healthcare news:
NorthStar Surgical Center turns 15: 3 things to know
30 things for ASC leaders to know for April
Strategic planning for established ASCs: Key thoughts physician-owned facilities
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
